Mesoblast pain drug agreement downgraded by German partner

MELBOURNE: Mesoblast and its German pharmaceutical partner GrĂ¼nenthal have downgraded their collaboration agreement ... read more

Imugene shares soar on US breast cancer trial

MELBOURNE: Cancer vaccine making biotech Imugene opened 8.6 per cent higher this morning ... read more

Hawaii holiday prize promised for vaccinated staff

SYDNEY: One of Australia’s largest fertility providers is offering staff the chance to ... read more

Lendlease keeps investors hanging as problems start to emerge

SYDNEY: Having officially been in the job only since June 1, Lendlease chief ... read more